secwatch / observer
8-K filed May 5, 2026, 7:59 PM ET ticker PALX CIK 0001938569
other material confidence high sentiment neutral materiality 0.60

Palomino Labs completes $1.88M second closing of private placement; total proceeds $16.98M

Palomino Laboratories Inc.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Palomino Laboratories Inc. issued 374,761 warrants of warrant to Laidlaw & Company (UK) Ltd. for services as placement agent.

Security
warrant
Shares
374,761 warrants
Purchaser
Laidlaw & Company (UK) Ltd.
Consideration
services as placement agent
Exact text from the filing
The Placement Agent also received 374,761 warrants to purchase shares of Common Stock which are exercisable for five (5) years and have an exercise price equal to 120% of the lowest price per share of the shares of Common Stock issued or issuable to investors in the Offering (the “ Placement Agent Warrants ”).
View on SEC.gov
Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Palomino Laboratories Inc. issued 470,000 Shares of common stock to certain accredited investors for gross proceeds of $1,880,000.00.

Security
common stock
Shares
470,000 Shares
Purchaser
certain accredited investors
Consideration
gross proceeds of $1,880,000.00
Exact text from the filing
On April 30, 2026, the Company and certain accredited investors mutually agreed to effect, and effected, an additional closing, with respect to 470,000 Shares for gross proceeds of $1,880,000.00 (the “ Second Closing ”).
View on SEC.gov

Browse all equity issuances →

Palomino Laboratories Inc. filing history →

Source: SEC EDGAR
accession 0001493152-26-021282
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.